Medical Doctor (M.D.) graduated by Medical School of the University of Sao Paulo (1991).
Title of Specialist Doctor in Homeopathy conferred by Brazilian Medical Association and by Brazilian Homeopathic Medical Association (1996).
PhD in Medical Sciences by Medical School of the University of Sao Paulo (2009).
Post-doctoral at the Medical School of the University of Sao Paulo (2017).
Author's Website: http://www.homeozulian.med.br
The use of nosodes for the prevention of epidemic diseases (isoprophylaxis), i.e., selected based on the 'principle of etiological identity' with full neglect of symptom-based individualization and pathogenetic trials, is not supported by the homeopathic epistemological model.
Similia Similibus Curentur is the foundation of Homeopathy; by applying the principle of therapeutic similarity, homeopathy seeks to stimulate the organism to react against its own disturbs. For homeopathic medicines to awaken effective homeostasis responses they must be individualized, this means that they must be chosen according to their similarity to the set of characteristic symptoms in patients.
This paper presents a protocol with the objective of investigating, in a randomized, double-blind and placebo-controlled clinical trial, the effectiveness and safety of possible individualized homeopathic drugs of epidemic genius of COVID-19, in adjuvant and complementary treatment of patients affected by the disease. If effectiveness and safety of medicine chosen is confirmed using this protocol, the medicine may be used in a generalized and collective manner in the treatment and prevention of the current epidemic.